-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FeyvdfKx26iOZ0ucrgAcp8GI+fD1uhG4ZrjGEzmHoX/yc6LIDK/q7q30g+MG+oaP 143ZGxFOXLldjqhsek1EZw== 0000927016-02-000655.txt : 20020414 0000927016-02-000655.hdr.sgml : 20020414 ACCESSION NUMBER: 0000927016-02-000655 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020211 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BURR EGAN DELEAGE & CO CENTRAL INDEX KEY: 0000902033 IRS NUMBER: 770189481 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE POST OFFICE SQUARE CITY: BOSTON STATE: MA ZIP: 02109 MAIL ADDRESS: STREET 1: ONE POST OFFICE SQUARE CITY: BOSTON STATE: MA ZIP: 02109 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INSPIRE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001040416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043209022 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60379 FILM NUMBER: 02534569 BUSINESS ADDRESS: STREET 1: 4222 EMPEROR BLVD STE 470 CITY: DURHAM STATE: NC ZIP: 27703-8466 BUSINESS PHONE: 9199419777 MAIL ADDRESS: STREET 1: 4222 EMPEROR BLVD STREET 2: STE 470 CITY: DURHAM STATE: NC ZIP: 27703-8466 SC 13G/A 1 dsc13ga.txt SCHEDULE 13G AMENDMENT #1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G (Amendment No. 1)* UNDER THE SECURITIES EXCHANGE ACT OF 1934 INSPIRE PHARMACEUTICALS, INC. --------------------------------------------------- (Name of Issuer) Common Stock --------------------------------------------------- (Title of Class of Securities) 457733 10 3 --------------------------------------------------- (CUSIP Number) December 31, 2001 - -------------------------------------------------------------------------------- (Date of Event, Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |_| Rule 13d-1(c) |_| Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 457733 10 3 Page 2 of 5 Pages (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Burr, Egan, Deleage & Co. 04-2681308 - -------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- (3) SEC Use Only - -------------------------------------------------------------------------------- (4) Citizenship or Place of Organization Massachusetts - -------------------------------------------------------------------------------- Number Of Shares (5) Sole Voting Power -0- Beneficially Owned By Each Reporting (6) Shared Voting Power 1,792,786 Person With Please also refer to Attachment A (7) Sole Dispositive Power -0- (8) Shared Dispositive Power 1,792,786 Please also refer to Attachment A (9) Aggregate Amount Beneficially Owned By Each Reporting Person 1,792,786 Please also refer to Attachment A - -------------------------------------------------------------------------------- (10) Check If The Aggregate Amount In Row (11) Excludes Certain Shares* - -------------------------------------------------------------------------------- (11) Percent Of Class Represented By Amount In Row (11) 7.0% Please also refer to Attachment A - -------------------------------------------------------------------------------- (12) Type Of Reporting Person IA - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Item 1. (a) Name of Issuer: Inspire Pharmaceuticals, Inc. ("Issuer") (b) Address of Issuer's Principal Executive Offices: 4222 Emperor Blvd. Suite 470 Durham, NC 27703 Item 2. (a) Name of Person Filing: Burr, Egan, Deleage & Co. (b) Address of Principal Business Office: 200 Clarendon St. Floor 51 Boston, MA 02116 (c) Citizenship/Place of Organization: Massachusetts (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 457733 10 3 Item 3. Not applicable Item 4. Ownership. (a) Amount Beneficially Owned: 1,792,786 (b) Percent of Class: 7.0% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote:N/A (ii) shared power to vote or to direct the vote: 1,792,786 Please also refer to Attachment A (iii) sole power to dispose or to direct the disposition of: N/A (iv) shared power to dispose or to direct the disposition of: 1,792,786 Please also refer to Attachment A Item 5. Ownership of Five Percent or Less of a Class Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable Item 8. Identification and Classification of Members of the Group No reporting person is a member of a group as defined in Section 240.13d-1(b)(1)(ii)(H) of the Act. Item 9. Notice of Dissolution of Group Not applicable Item 10. Certification Not applicable Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 11, 2002 Burr, Egan, Deleage & Co. By: /s/ Eileen McCarthy ------------------- Eileen McCarthy Vice President Attachment A / Inspire Pharmaceuticals, Inc. Burr, Egan, Deleage & Co. directly or indirectly provides investment advisory services to several venture capital funds including Alta V Limited Partnership and Customs House Partners. At December 31, 2001, the beneficial ownership is as follows: Alta V Limited Partnership 1,774,142 Common shares Customs House Partners 18,644 Common shares ----------------------- 1,792,786 Total common shares The respective general partners of these funds exercise sole voting and investment power with respect to the shares owned by such funds. The principals of Burr, Egan, Deleage & Co. are general partners of Alta V Management Partners, L.P. (the General Partner of Alta V Limited Partnership) and Customs House Partners. As general partners of these funds, they may be deemed to share voting and investment powers for the shares held by the funds. These principals disclaim beneficial ownership of all such shares held by the aforementioned funds except to the extent of their proportionate pecuniary interests therein. Terrance McGuire, a director of the company, is a general partner of Alta V Management Partners, L.P. (which is the general partner of Alta V Limited Partnership). As general partner of the fund, he may be deemed to share voting and investment powers with respect to the shares held by the fund. Mr. McGuire disclaims beneficial ownership of all the shares held by Alta V Limited Partnership except to the extent of his proportionate pecuniary interests therein. Mr. McGuire also disclaims beneficial ownership to all the shares of Customs House Partners. Mr. McGuire personally owns 11,498 shares of Common Stock of the Company. -----END PRIVACY-ENHANCED MESSAGE-----